What is the typical incidence of sapropterin side effects?

How common are mild side effects with sapropterin?
Most patients report only mild digestive upset, headache, or runny nose. In controlled studies these events occur at rates of roughly 5–10 percent and often resolve without stopping treatment.

How often do serious reactions appear?
Severe events remain rare. Fewer than 2 percent of patients in registration trials experienced low blood pressure, allergic rash, or elevated liver enzymes that required medical attention.

What side effects do patients search about most?
Online forums and safety databases show repeated questions about stomach pain, cough, and fatigue. These symptoms appear in post-marketing reports at frequencies similar to the trial data.

Do children and adults show different rates?
Pediatric cohorts report slightly higher rates of mild upper-respiratory symptoms (about 12 percent) compared with adults (8 percent), but the gap narrows after the first month of therapy.

Does long-term use change the safety picture?
Registry follow-up extending beyond five years has not identified new safety signals or cumulative toxicity. Incidence of any adverse event declines after the first year.

Can other medications increase side-effect risk?
Drugs that raise tetrahydrobiopterin levels, such as methotrexate, may intensify headache or gastrointestinal complaints. Clinicians usually adjust sapropterin dose rather than discontinue therapy.

When does patent protection end and what does that mean for cost?
The key U.S. composition-of-matter patent expires in 2026. Generic entry is expected to lower out-of-pocket cost by 60–80 percent once multiple suppliers reach the market.